Dr. Kumar’s Take:
This large randomized trial tested whether calcium and vitamin D supplements could prevent hip and other fractures in healthy postmenopausal women. Hip bone density came out slightly higher in the supplement group, but hip fractures were not significantly reduced. Kidney stones went up. The one signal worth noting: among women who actually kept taking their pills, the hip fracture reduction reached statistical significance.
My reading is that a supplement is not a fracture strategy on its own. Diet, weight-bearing exercise, and avoiding smoking and excess alcohol carry more weight than a pill does. I also note that this trial used 400 IU of vitamin D3, and it did not test vitamin K2 alongside vitamin D, which is a combination I pay attention to in my own practice.
Key Takeaways:
✔ Calcium and vitamin D raised hip bone density by 1.06 percent.
✔ Hip fracture was not significantly reduced overall (HR 0.88, 95% CI 0.72 to 1.08).
✔ Among women who stayed adherent, the hip fracture hazard ratio fell to 0.71 (95% CI 0.52 to 0.97).
✔ Kidney stone risk rose (HR 1.17, 95% CI 1.02 to 1.34).
Actionable tip:
If you and your doctor decide on calcium and vitamin D, consistency is the part that mattered in this trial: the benefit for hip fracture only reached significance once non-adherent women were censored. Weigh that against the increase in kidney stones, and talk to your doctor about whether supplementation fits your situation.
Study Summary: What This Research Was About
This randomized, placebo-controlled trial was part of the Women’s Health Initiative. It enrolled 36,282 postmenopausal women aged 50 to 79. Participants received either 1000 mg of elemental calcium as calcium carbonate with 400 IU of vitamin D3 daily, or placebo. Fractures were tracked over an average follow-up of 7.0 years, and bone density was measured at three WHI centers.
Study Design:
- Participants: 36,282 postmenopausal women (ages 50 to 79)
- Treatment: Daily calcium (1000 mg elemental, as calcium carbonate) plus vitamin D3 (400 IU) vs. placebo
- Duration: Average follow-up of 7.0 years
- Measured Outcomes: Hip fracture, clinical spine fracture, total fractures, hip bone density, renal calculi
- Additional Analysis: Results were examined by prerandomization serum vitamin D level, and with data censored once women stopped taking study medication
Results:
- Bone Density: Hip bone density was 1.06 percent higher in the supplement group (P<0.01).
- Fracture Risk:
- Hip fracture: hazard ratio 0.88 (95% CI 0.72 to 1.08), not statistically significant
- Clinical spine fracture: hazard ratio 0.90 (95% CI 0.74 to 1.10)
- Total fractures: hazard ratio 0.96 (95% CI 0.91 to 1.02)
- With data censored when women stopped taking study medication, the hip fracture hazard ratio was 0.71 (95% CI 0.52 to 0.97)
- Kidney Stones: Hazard ratio 1.17 (95% CI 1.02 to 1.34)
- Baseline Vitamin D: Effects did not vary significantly according to prerandomization serum vitamin D levels
Interpreting the Findings
The intention-to-treat result is the honest headline: calcium with vitamin D produced a small but significant gain in hip bone density and did not significantly reduce hip fracture. The analysis that censored each woman’s data once she stopped taking the study medication is more encouraging, but it steps away from the randomized comparison, so I treat it as suggestive rather than settled. The vitamin D dose here was 400 IU. Baseline vitamin D level did not change the answer in this trial. Vitamin K2 was not part of this study.
Related Studies and Research
Global Prevalence of Vitamin D Deficiency: A Meta-Analysis. Sheds light on deficiency’s role in fracture risk.
Trial Assessing Vitamin D Supplementation’s Impact on Fall Risk Among Nursing Home Residents. Connects improved balance and bone strength.
Role of Vitamin D and Calcium in Type 2 Diabetes Prevention: A Systematic Review and Meta-Analysis. Explores metabolic effects of Ca + D beyond bone.
Vitamin D Deficiency: Clinical Review by Michael F. Holick, MD, PhD. Summarizes fracture prevention strategies in older adults.
Frequently Asked Questions
Should all postmenopausal women take calcium and vitamin D?
This trial does not support a blanket yes. In healthy postmenopausal women aged 50 to 79, the supplement combination improved hip bone density slightly but did not significantly reduce hip fracture, and it raised kidney stone risk. Whether it makes sense for you is a conversation to have with your doctor about your own bone density, fracture history, and stone history.
Can these supplements replace other osteoporosis treatments?
No. In this trial, calcium with vitamin D did not significantly reduce hip fracture, clinical spine fracture, or total fractures. It is a supporting measure, not a substitute for prescription osteoporosis therapy when that is indicated.
What is the risk of kidney stones?
Renal calculi were more common with calcium plus vitamin D, with a hazard ratio of 1.17 (95% CI 1.02 to 1.34). If you are supplementing, drink plenty of fluids and account for calcium you are already getting from other sources.
Is 400 IU of vitamin D enough?
This trial used 400 IU daily, and at that dose hip fracture was not significantly reduced in the intention-to-treat analysis. Baseline vitamin D level did not modify the effect. What dose is right for you depends on your blood level, so ask your doctor to check it.
Conclusion
This WHI trial found a small but significant improvement in hip bone density with calcium plus vitamin D, no significant reduction in hip fracture, and an increased risk of kidney stones. The hip fracture benefit reached significance only when the analysis was restricted to women who kept taking the supplement. I read that as a modest result that belongs alongside diet, exercise, and, where it is indicated, actual osteoporosis treatment.
